Telithromycin activity is reduced by efflux in Streptococcus pyogenes

被引:17
作者
Cantón, R
Mazzariol, A
Morosini, MI
Baquero, F
Cornaglia, G
机构
[1] Sez Microbiol, Dipartimento Patol, I-37134 Verona, Italy
[2] Hosp Univ Ramon y Cajal, Microbiol Serv, Madrid 28034, Spain
关键词
ketolides; macrolides; antimicrobial resistance;
D O I
10.1093/jac/dki033
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate whether telithromycin is a substrate for efflux pumps in Streptococcus pyogenes. Methods: The distribution of telithromycin MICs was analysed for two distinct collections of Italian (n=486) and Spanish (n=210) S. pyogenes strains. The effect of an efflux mechanism was investigated using [H-3]telithromycin. Results: Telithromycin MIC ranges were <= 0.004-0.06 mg/L (MIC50 and MIC90, 0.01 mg/L) in erythromycin-susceptible strains (lacking both mef and erm genes) and 0.01-1 mg/L (MIC50 and MIC90, 0.5 mg/L) in strains endowed with the M phenotype and expressing the mef(A) gene. A distinct telithromycin efflux was detected in the strains expressing the mef(A) gene, but not in those expressing the erm(B) gene, nor in the susceptible strains lacking mef(A) or erm genes. Efflux reversibility by addition of an inhibiting compound (sodium arsenate) was demonstrated. An msr-like sequence was also found in all strains effluxing telithromycin, but not in the others. Conclusions: This study shows that telithromycin can be removed from S. pyogenes by efflux. That the efflux is related to the presence of the mef(A) gene is demonstrated, but-owing to the increasingly evident complexity of S. pyogenes efflux systems-the possibility that other genes may contribute to the efflux cannot be excluded.
引用
收藏
页码:489 / 495
页数:7
相关论文
共 37 条
[1]   Streptococcus pyogenes erythromycin resistance in Italy [J].
Bassetti, M ;
Mantero, E ;
Gatti, G ;
Di Biagio, A ;
Bassetti, D .
EMERGING INFECTIOUS DISEASES, 1999, 5 (02) :302-303
[2]   In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes:: Influences of resistance mechanisms and methodological factors [J].
Bemer-Melchior, P ;
Juvin, ME ;
Tassin, S ;
Bryskier, A ;
Schito, GC ;
Drugeon, HB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :2999-3002
[3]   Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin [J].
Betriu, C ;
Culebras, E ;
Redondo, M ;
Rodríguez-Avial, I ;
Gómez, M ;
Boloix, A ;
Picazo, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) :436-U11
[4]   Emergence of macrolide-resistant Streptococcus pyogenes strains in French children [J].
Bingen, E ;
Bidet, P ;
Mihaila-Amrouche, L ;
Doit, C ;
Forcet, S ;
Brahimi, N ;
Bouvet, A ;
Cohen, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3559-3562
[5]   Emergence of group a streptococcus strains with different mechanisms of macrolide resistance [J].
Bingen, E ;
Leclercq, R ;
Fitoussi, F ;
Brahimi, N ;
Malbruny, B ;
Deforche, D ;
Cohen, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1199-1203
[6]   Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe [J].
Bozdogan, B ;
Appelbaum, PC ;
Kelly, LM ;
Hoellman, DB ;
Tambic-Andrasevic, A ;
Drukalska, L ;
Hryniewicz, W ;
Hupkova, H ;
Jacobs, MR ;
Kolman, J ;
Konkoly-Thege, M ;
Miciuleviciene, J ;
Pana, M ;
Setchanova, L ;
Trupl, J ;
Urbaskova, P .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) :741-745
[7]   Ketolides - telithromycin, an example of a new class of antibacterial agents [J].
Bryskier, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (12) :661-669
[8]   Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000 [J].
Cantón, R ;
Loza, E ;
Morosini, MI ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :9-24
[9]   The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli [J].
Chollet, R ;
Chevalier, J ;
Bryskier, A ;
Pagés, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3621-3624
[10]   Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae [J].
Clancy, J ;
DibHajj, F ;
Petitpas, JW ;
Yuan, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (12) :2719-2723